NOLTE ALEXANDER (Chief Accounting Officer) sold 968.00 shares of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $16.1K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/3/2022ACC: 0001562180-22-001077
Officer· Chief Accounting Officer
Since Oct 2021
+30K
Net shares
Net buyer
$16.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
30.97K acquired · 968.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+968.00
Price / share
$12.39
Trade value
$11.99K
% of position
New position
1/31/2022
0.00→968.00
Common Stock
Direct
Shares
−968.00
Price / share
$16.65
Trade value
$16.12K
% of position
New position
2/1/2022
968.00→0.00
Total
Net shares
+0.00
Net value
-$4.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2022 | J · J | +968.00 | $12.39 | $11.99K | New position | 0.00 | 968.00 |
| Common Stock Direct | 2/1/2022 | S · Sale | −968.00 | $16.65 | $16.12K | New position | 968.00 | 0.00 |
| Total | +0.00 | -$4.12K | ||||||
Derivative Transactions1
Stock Options (Right to buy)
Direct
Converts to
Common Stock
30K shares
Shares
+30K
Strike price
15.79
Held after
30K
Exercisable
—
2/2/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) Direct | Common Stock30K shares | 2/2/2022 | A · Award | +30K | 15.79 | — | 30K |